Tentative Provisions for the Administration of the Designation of a Domestic Responsible Person by Foreign Marketing Authorization Holders

境外药品上市许可持有人指定境内责任人管理暂行规定

Foreign marketing authorization holders are required to designate a domestic responsible person in China ; Clp Reference: 2600/24.11.13 ; Issued: 2024-11-13 ; Effective: 2025-07-01

.

(Issued by the National Medical Products Administration on November 13, 2024 and effective as of July 1, 2025.)

(国家药品监督管理局于二零二四年十一月十三日发布，自二零二五年七月一日起施行。)

NMPA Announcement No.137

国家药监局公告 第137号

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]